Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to $102000.0.

  • GoHealth's Gains from Investment Securities fell 3154.36% to $102000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 20311.58%. This contributed to the annual value of $1.5 million for FY2024, which is 3420.48% down from last year.
  • Latest data reveals that GoHealth reported Gains from Investment Securities of $102000.0 as of Q3 2025, which was down 3154.36% from $4.2 million recorded in Q2 2025.
  • GoHealth's 5-year Gains from Investment Securities high stood at $4.2 million for Q2 2025, and its period low was -$289000.0 during Q4 2021.
  • Moreover, its 5-year median value for Gains from Investment Securities was $183000.0 (2023), whereas its average is $511777.8.
  • In the last 5 years, GoHealth's Gains from Investment Securities tumbled by 10152.46% in 2021 and then skyrocketed by 98048.78% in 2023.
  • GoHealth's Gains from Investment Securities (Quarter) stood at -$289000.0 in 2021, then surged by 40.48% to -$172000.0 in 2022, then surged by 226.16% to $217000.0 in 2023, then crashed by 88.02% to $26000.0 in 2024, then skyrocketed by 292.31% to $102000.0 in 2025.
  • Its last three reported values are $102000.0 in Q3 2025, $4.2 million for Q2 2025, and $822000.0 during Q1 2025.